Literature DB >> 28236163

Comparison of Patients Undergoing Surgical Versus Transcatheter Pulmonary Valve Replacement: Criteria for Referral and Mid-Term Outcome.

Jenny E Zablah1,2, Nilanjana Misra3, Dorota Gruber3, Dipak Kholwadwala3, Shilpi Epstein3.   

Abstract

Pulmonary regurgitation and/or stenosis (PS) is challenging in patients with congenital heart defects. Our aim was to identify if criteria for referral were different between surgical (SPVR) and transcatheter pulmonary valve replacement (TPVR) populations, and to further assess if any baseline differences influence the resultant ventricular remodeling at medium-term follow-up. Retrospective chart review of patients post-SPVR or TPVR at our center from 2013 to 2015 was conducted. Volumetric data from cardiac magnetic resonance (CMR), 1 year before and 1 year after PVR was obtained. PS was defined as peak-peak gradient ≥35 mmHg by catheterization or peak gradient ≥50 mmHg by echocardiography. Thirty patients underwent PVR: 15 SPVR and 15 TPVR (1 hybrid). The indications for SPVR referral were: 2+ CMR parameters in 80% of patients; decreased left ventricular ejection fraction and hemodynamic findings and/or abnormal exercise stress test in 20%. The indications for TPVR referral were predominantly symptoms ± hemodynamic findings in 66% of patients, 2+ CMR findings in 44% of patients. At referral, SPVR group had significantly larger right ventricular (RV) volumes than TPVR group. Biventricular function was not significantly different. Post-PVR, both groups had significantly decreased RV volumes and increased LV diastolic volumes. The SPVR group improved LV cardiac output and biventricular function whereas TPVR group had no significant improvement. The patients in the SPVR group were mostly referred based on CMR volumetric criteria, whereas the patients in the TPVR group were mostly referred due to exercise intolerance with only occasional abnormalities on CMR. 1 year after PVR, both groups had near-normal biventricular volumes and function irrespective of characteristics at referral.

Entities:  

Keywords:  Melody valve; Pulmonary valve replacement; Right ventricular remodeling

Mesh:

Year:  2017        PMID: 28236163     DOI: 10.1007/s00246-016-1554-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects.

Authors:  Louise Coats; Sachin Khambadkone; Graham Derrick; Shankar Sridharan; Silvia Schievano; Bryan Mist; Rod Jones; John E Deanfield; Denis Pellerin; Philipp Bonhoeffer; Andrew M Taylor
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.

Authors:  Doff B McElhinney; William E Hellenbrand; Evan M Zahn; Thomas K Jones; John P Cheatham; James E Lock; Julie A Vincent
Journal:  Circulation       Date:  2010-07-19       Impact factor: 29.690

3.  Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery.

Authors:  Tal Geva; Kimberlee Gauvreau; Andrew J Powell; Frank Cecchin; Jonathan Rhodes; Judith Geva; Pedro del Nido
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

4.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

5.  Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?

Authors:  Alessandra Frigiola; Victor Tsang; Catherine Bull; Louise Coats; Sachin Khambadkone; Graham Derrick; Bryan Mist; Fiona Walker; Carin van Doorn; Philipp Bonhoeffer; Andrew M Taylor
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

6.  Physiological consequences of percutaneous pulmonary valve implantation: the different behaviour of volume- and pressure-overloaded ventricles.

Authors:  Louise Coats; Sachin Khambadkone; Graham Derrick; Marina Hughes; Rod Jones; Bryan Mist; Denis Pellerin; Jan Marek; John E Deanfield; Philipp Bonhoeffer; Andrew M Taylor
Journal:  Eur Heart J       Date:  2007-06-26       Impact factor: 29.983

7.  Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues.

Authors:  Tal Geva
Journal:  Circulation       Date:  2013-09-24       Impact factor: 29.690

8.  Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance.

Authors:  Thomas Oosterhof; Alexander van Straten; Hubert W Vliegen; Folkert J Meijboom; Arie P J van Dijk; Anje M Spijkerboer; Berto J Bouma; Aeilko H Zwinderman; Mark G Hazekamp; Albert de Roos; Barbara J M Mulder
Journal:  Circulation       Date:  2007-07-09       Impact factor: 29.690

Review 9.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Authors:  Tal Geva
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-20       Impact factor: 5.364

Review 10.  What is new in pediatric cardiac imaging?

Authors:  Luc Mertens; Javier Ganame; Bénédicte Eyskens
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.